Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

Delayed Data
As of Oct 20
 +0.07 / +0.12%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 69.00, with a high estimate of 130.00 and a low estimate of 58.00. The median estimate represents a +16.89% increase from the last price of 59.03.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 28.31%
Growthannually -48.04%


Growthquarterly 360.71%
Growthannually 388.86%
Key to the earnings and sales forecast charts.